Tetanus-diphtheria vaccine can prime SARS-CoV-2 cross-reactive T cells.

Saved in:

Bibliographic Details
Title:	Tetanus-diphtheria vaccine can prime SARS-CoV-2 cross-reactive T cells.
Authors:	Fernandez SA; Department of Immunology & O2, Faculty of Medicine, Complutense University of Madrid, Ciudad Universitaria, Madrid, Spain., Pelaez-Prestel HF; Department of Immunology & O2, Faculty of Medicine, Complutense University of Madrid, Ciudad Universitaria, Madrid, Spain., Fiyouzi T; Department of Immunology & O2, Faculty of Medicine, Complutense University of Madrid, Ciudad Universitaria, Madrid, Spain., Gomez-Perosanz M; Department of Immunology & O2, Faculty of Medicine, Complutense University of Madrid, Ciudad Universitaria, Madrid, Spain., Reiné J; Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.; Oxford Vaccine Group, University of Oxford, Oxford, United Kingdom., Reche PA; Department of Immunology & O2, Faculty of Medicine, Complutense University of Madrid, Ciudad Universitaria, Madrid, Spain.
Source:	Frontiers in immunology [Front Immunol] 2024 Jul 18; Vol. 15, pp. 1425374. Date of Electronic Publication: 2024 Jul 18 (Print Publication: 2024).
Publication Type:	Journal Article
Journal Info:	Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Database:	MEDLINE Ultimate

Description
ISSN:	1664-3224
DOI:	10.3389/fimmu.2024.1425374